223 related articles for article (PubMed ID: 31506393)
1. Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin.
Rai Y; Yadav P; Kumari N; Kalra N; Bhatt AN
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31506393
[TBL] [Abstract][Full Text] [Related]
2. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
Yoo JJ; Yu SJ; Na J; Kim K; Cho YY; Lee YB; Cho EJ; Lee JH; Kim YJ; Youn H; Yoon JH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875800
[TBL] [Abstract][Full Text] [Related]
3. 3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells.
Sun X; Sun G; Huang Y; Hao Y; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
Biochem Pharmacol; 2020 Jul; 177():113988. PubMed ID: 32330495
[TBL] [Abstract][Full Text] [Related]
4. Intraclonal heterogeneity in the in vitro daunorubicin-induced apoptosis in acute myeloid leukemia.
Palucka KA; Knaust E; Xu D; Macnamara B; Porwit-Macdonald A; Gruber A; Peterson C; Björkholm M; Pisa P
Leuk Lymphoma; 1999 Jan; 32(3-4):309-16. PubMed ID: 10037028
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines.
Zheng B; Zhou R; Gong Y; Yang X; Shan Q
Int J Lab Hematol; 2012 Jun; 34(3):237-47. PubMed ID: 22145750
[TBL] [Abstract][Full Text] [Related]
6. Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells : ROS-mediated cell death by 3-BrPA.
Kim JS; Ahn KJ; Kim JA; Kim HM; Lee JD; Lee JM; Kim SJ; Park JH
J Bioenerg Biomembr; 2008 Dec; 40(6):607-18. PubMed ID: 19067133
[TBL] [Abstract][Full Text] [Related]
7. Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells.
Matsunaga T; Yamaguchi A; Morikawa Y; Kezuka C; Takazawa H; Endo S; El-Kabbani O; Tajima K; Ikari A; Hara A
Anticancer Drugs; 2014 Sep; 25(8):868-77. PubMed ID: 24743520
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma.
Kim W; Yoon JH; Jeong JM; Cheon GJ; Lee TS; Yang JI; Park SC; Lee HS
Mol Cancer Ther; 2007 Sep; 6(9):2554-62. PubMed ID: 17876052
[TBL] [Abstract][Full Text] [Related]
9. [Expression of hexokinase-II gene in human colon cancer cells and the therapeutic significance of inhibition thereof].
Peng QP; Liang HJ; Zhou Q; Zhou JM; Fu XL; Zhong DP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1058-62. PubMed ID: 17672972
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition.
Yu SJ; Yoon JH; Yang JI; Cho EJ; Kwak MS; Jang ES; Lee JH; Kim YJ; Lee HS; Kim CY
J Bioenerg Biomembr; 2012 Feb; 44(1):101-15. PubMed ID: 22350012
[TBL] [Abstract][Full Text] [Related]
11. The Combination of Flavokawain B and Daunorubicin Induces Apoptosis in Human Myeloid Leukemic Cells by Modifying NF-κB.
Lee JJ; Koh KN; Park CJ; Jang S; Im HJ; Kim N
Anticancer Res; 2018 May; 38(5):2771-2778. PubMed ID: 29715098
[TBL] [Abstract][Full Text] [Related]
12. Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase.
Rodrigues-Ferreira C; da Silva AP; Galina A
J Bioenerg Biomembr; 2012 Feb; 44(1):39-49. PubMed ID: 22322891
[TBL] [Abstract][Full Text] [Related]
13. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.
Mathupala SP; Ko YH; Pedersen PL
Semin Cancer Biol; 2009 Feb; 19(1):17-24. PubMed ID: 19101634
[TBL] [Abstract][Full Text] [Related]
14. The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression.
Ho N; Morrison J; Silva A; Coomber BL
Biosci Rep; 2016 Jan; 36(1):e00299. PubMed ID: 26740252
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines.
Grazide S; Terrisse AD; Lerouge S; Laurent G; Jaffrézou JP
J Biol Chem; 2004 Apr; 279(18):18256-61. PubMed ID: 14766899
[TBL] [Abstract][Full Text] [Related]
16. (6)-Gingerolinduced myeloid leukemia cell death is initiated by reactive oxygen species and activation of miR-27b expression.
Rastogi N; Gara RK; Trivedi R; Singh A; Dixit P; Maurya R; Duggal S; Bhatt ML; Singh S; Mishra DP
Free Radic Biol Med; 2014 Mar; 68():288-301. PubMed ID: 24378438
[TBL] [Abstract][Full Text] [Related]
17. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.
Cao X; Fang L; Gibbs S; Huang Y; Dai Z; Wen P; Zheng X; Sadee W; Sun D
Cancer Chemother Pharmacol; 2007 Mar; 59(4):495-505. PubMed ID: 16906425
[TBL] [Abstract][Full Text] [Related]
18. Two distinct modes of oncoprotein expression during apoptosis resistance in vincristine and daunorubicin multidrug-resistant HL60 cells.
Belhoussine R; Morjani H; Gillet R; Palissot V; Manfait M
Adv Exp Med Biol; 1999; 457():365-81. PubMed ID: 10500812
[TBL] [Abstract][Full Text] [Related]
19. The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis.
Nikravesh H; Khodayar MJ; Behmanesh B; Mahdavinia M; Teimoori A; Alboghobeish S; Zeidooni L
BMC Cancer; 2021 Aug; 21(1):903. PubMed ID: 34364387
[TBL] [Abstract][Full Text] [Related]
20. Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate.
Chen Z; Zhang H; Lu W; Huang P
Biochim Biophys Acta; 2009 May; 1787(5):553-60. PubMed ID: 19285479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
